Researchers Discover How the Bacterium Staphylococcus Aureus Colonises the Nose

Researchers Discover How the Bacterium Staphylococcus Aureus Colonises the Nose
share Share

A collaboration between researchers at the School of Biochemistry and Immunology and the Department of Microbiology at Trinity College Dublin has identified a mechanism by which the bacterium Staphylococcus aureus (S. aureus) colonises our nasal passages. The study, recently published in the prestigious journal PLOS Pathogens, shows for the first time that a protein located on the bacterial surface called clumping factor B (ClfB) recognises a protein called loricrin that is a major component of the envelope of cells in the nose and skin. 

S. aureus is an important human pathogen, with the potential to cause severe invasive diseases. It is a major concern in hospitals and healthcare facilities, where many infections are caused by strains such as MRSA  that are resistant to commonly used antibiotics.  Interestingly, S. aureus persistently colonises about 20% of the human population by binding to skin-like cells within the nasal cavity. Being colonised predisposes an individual towards becoming infected so it is vital that we understand the mechanisms involved.  

ClfB was previously shown to promote S. aureus colonisation in a human nasal volunteer study. This paper now identifies the mechanism by which ClfB facilitates S. aureus nasal colonisation. ClfB binding to loricrin was shown to be crucial for successful colonisation of the nose in a mouse model.  A mouse lacking loricrin allowed fewer bacterial cells to colonise its nasal passages than a normal mouse. When S. aureus strains that lacked ClfB were used nasal colonisation was dramatically  reduced. Finally it was shown that soluble loricrin could reduce binding of S. aureus to human nasal skin cells and that nasal administration of loricrin reduced S. aureus colonisation of mice.

Trinity’s Assistant Professor at the School of Biochemistry and Immunology Rachel McLoughlin  and Professor of Molecular Microbiology Tim Foster, the study’s corresponding authors concluded: “Loricrin is a major determinant of S. aureus nasal colonisation. This discovery opens new avenues for developing therapeutic strategies to reduce the burden of nasal carriage and consequently infections with this bacterium. This is particularly important given the difficulties associated with treating MRSA infections”.

This project was supported by a Science Foundation Ireland Programme Investigator award and the Wellcome Trust. 

To read the paper in full please visit:

«« Using Health Services Must Not Break Family Finances

CVD Data to be Standardised Across Europe »»

Published on : Tue, 5 Mar 2013

Related Articles

Toshiba has unveiled a ground-breaking scientific co-operation with one of the world’s leading centres for research into dementia... Read more

On 21 February 2013, WHO issued its recommendation for the composition of influenza vaccines for the 2013-2014 influenza season... Read more

At the start of its 'European Month of the Brain' initiative, the European Commission has earmarked some €150 million of funding... Read more

Infections, Research <p style="display: inline; float: none; ">A collaboration between researchers at the School of Biochemistry and Immunology and the Department of Microbiolo...

No comment

Please login to leave a comment...

Highlighted Products